Assignee
GLAXOSMITHKLINE IP NO 2 LTD
GB·68 granted patents·47 pending applications·95 citations·filing 2012–2025
Top patents by PatentIndex Score
115 records- 0195US11459384B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2022·Granted Oct 4, 2022·3 cites·25 claims
- 0294US11299541B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted Apr 12, 2022·3 cites·19 claims
- 0394US11286298B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted Mar 29, 2022·3 cites·17 claims
- 0494US11274148B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted Mar 15, 2022·3 cites·18 claims
- 0592US10870695B2Biopharmaceutical compositions comprising interleukin-5 antibodyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Dec 22, 2020·8 cites·12 claims
- 0690US8957104B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2013·Granted Feb 17, 2015·10 cites·12 claims
- 0790US2026049130A1Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2025·Application pending·0 cites
- 0889US11117871B2Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Sep 14, 2021·2 cites·16 claims
- 0988US12187790B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2024·Granted Jan 7, 2025·0 cites·17 claims
- 1088US12187791B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2024·Granted Jan 7, 2025·0 cites·17 claims
- 1188US12187789B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2024·Granted Jan 7, 2025·0 cites·22 claims
- 1288US10034881B22,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Jul 31, 2018·6 cites·4 claims
- 1386US10316054B2Preparation and use of crystalline beta-D-nicotinamide ribosideGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Jun 11, 2019·6 cites·20 claims
- 1486US9346840B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted May 24, 2016·7 cites·12 claims
- 1586US9273069B2Compounds as diacylglycerol acyltransferase inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Mar 1, 2016·4 cites·8 claims
- 1685US10370356B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Aug 6, 2019·6 cites·20 claims
- 1785US10196353B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Feb 5, 2019·3 cites·12 claims
- 1885US9040517B2Compounds as diacylglycerol acyltransferase inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted May 26, 2015·5 cites·8 claims
- 1983US12454571B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2022·Granted Oct 28, 2025·0 cites·13 claims
- 2083US10710963B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Jul 14, 2020·1 cites·4 claims
- 2181US10676503B2Methods for purifying antibodiesGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted Jun 9, 2020·4 cites·18 claims
- 2280US9902694B2Crystalline formsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Feb 27, 2018·3 cites·8 claims
- 2379US10583112B2Benzo[b]furans as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 10, 2020·2 cites·22 claims
- 2478US2023040299A12,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2022·Application pending·0 cites
- 2577US10064854B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Sep 4, 2018·1 cites·14 claims
- 2676US10428026B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Oct 1, 2019·2 cites·25 claims
- 2775US10858376B2Tricyclic benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Dec 8, 2020·0 cites·18 claims
- 2875US10562852B2Crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrileGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Feb 18, 2020·1 cites·12 claims
- 2975US10202386B2Pyrrolo[3,2-D]pyrimidine derivatives as inducers of human interferonGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Feb 12, 2019·2 cites·18 claims
- 3075US10059699B2Tetrahydroquinoline derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Aug 28, 2018·2 cites·18 claims
- 3175US2025353878A1Methods of Purifying AntibodiesGLAXOSMITHKLINE IP NO 2 LTD·Filed 2025·Application pending·0 cites
- 3275US2023271927A1Crystalline forms of gsk1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2023·Application pending·0 cites
- 3375US2026035371A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2025·Application pending·0 cites
- 3473US11299457B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Apr 12, 2022·0 cites·4 claims
- 3573US10966961B2Pyrazole derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Apr 6, 2021·1 cites·17 claims
- 3673US10485814B2Nicotinamide riboside analogs and pharmaceutical compositions and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Nov 26, 2019·2 cites·18 claims
- 3773US2021053999A1Tricyclic Benzoxaborole Compounds and Uses ThereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Application pending·0 cites
- 3872US12240853B2Compounds useful in HIV therapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Mar 4, 2025·0 cites·16 claims
- 3971US11649217B2Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted May 16, 2023·0 cites·18 claims
- 4071US2020199219A1Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Application pending·0 cites
- 4170US11478478B22,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Oct 25, 2022·0 cites·21 claims
- 4269US10588891B2TRPV4 antagonistsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 17, 2020·1 cites·21 claims
- 4368US10526352B2Tricyclic benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Jan 7, 2020·0 cites·13 claims
- 4466US10927080B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Feb 23, 2021·0 cites·8 claims
- 4566US10583139B22,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Mar 10, 2020·0 cites·16 claims
- 4666US9242962B2Method of treatmentGLAXOSMITHKLINE IP NO 2 LTD·Filed 2012·Granted Jan 26, 2016·2 cites·4 claims
- 4765US11214582B24-substituted benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Jan 4, 2022·0 cites·20 claims
- 4864US12358945B2Methods for purifying antibodiesGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Jul 15, 2025·0 cites·20 claims
- 4963US10308668B2Tricyclic benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Jun 4, 2019·0 cites·22 claims
- 5062US11001556B2Crystalline formsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted May 11, 2021·0 cites·12 claims
Showing the top 50 of 115 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GLAXOSMITHKLINE IP NO 2 LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →